April 13, 2026 · Form 4 insider transaction
Rodman David Malcom sold 14,058 shares of Mineralys Therapeutics, Inc. at $26.54 per share, a transaction worth $373.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.; The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.3676 to $26.8400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.